Drug Shortage Report for TARO-CARBAMAZEPINE

Last updated on 2022-12-12 History
Report ID 31631
Drug Identification Number 02407515
Brand name TARO-CARBAMAZEPINE
Common or Proper name TARO CARBAMAZEPINE
Company Name TARO PHARMACEUTICALS INC
Market Status DORMANT
Active Ingredient(s) CARBAMAZEPINE
Strength(s) 200MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 500's
ATC code N03AF
ATC description ANTIEPILEPTICS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2018-10-29
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-12-12
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 130 EAST DRIVE
BRAMPTON, ONTARIO
CANADA L6T 1C1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v1 2017-12-04 English Compare
v2 2017-12-04 French Compare
v3 2017-12-25 English Compare
v4 2017-12-25 French Compare
v5 2017-12-25 English Compare
v6 2017-12-25 French Compare
v7 2018-01-18 English Compare
v8 2018-01-18 French Compare
v9 2018-01-19 English Compare
v10 2018-01-19 French Compare
v11 2018-02-02 English Compare
v12 2018-02-02 French Compare
v13 2018-02-23 English Compare
v14 2018-02-23 French Compare
v15 2018-03-05 English Compare
v16 2018-03-05 French Compare
v17 2018-03-05 English Compare
v18 2018-03-05 French Compare
v19 2018-05-25 English Compare
v20 2018-05-25 French Compare

Showing 1 to 20 of 76